MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Clinical trials for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS trials appear
Sign up with your email to follow new studies for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to sharpen diagnosis of rare nerve disease
Diagnosis Recruiting nowThis study looks at two different lab tests to see which one is better at diagnosing a rare autoimmune disease called MOGAD, which affects the nerves. Researchers will test 240 adults who are suspected of having MOGAD, as well as people with other nerve conditions, to compare the…
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Huashan Hospital • Aim: Diagnosis
Last updated May 17, 2026 06:21 UTC
-
New study to uncover how MS and its treatments affect pregnancy and child health
Knowledge-focused Recruiting nowThis study is a French registry that follows 1,500 pregnant women with multiple sclerosis (MS) or related conditions, along with their children. The goal is to learn how the disease and medications used during pregnancy affect both mother and child. Researchers will track relapse…
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 17, 2026 06:21 UTC